Skip to content
Home/Companies/Biotech/CamGene Therapeutics
CT

CamGene Therapeutics

Biotech·United Kingdom·Active·1yr hold

CamGene Therapeutics is a biotech company, headquartered in United Kingdom.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns CamGene Therapeutics?

CamGene Therapeutics is currently owned by Parkwalk Advisors through Parkwalk Opportunities EIS Fund (2009 vintage), since 2025.

Hand-verified · updated 2026-07-24

Parkwalk Advisors
Investor
Parkwalk Advisors
Parkwalk Opportunities EIS Fund · 2009 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Parkwalk Opportunities EIS Fund

Other portfolio companies in the same fund.

1715 Labs
Exited 2023
AI/MLUK
ACAL Energy
Exited 2017
EnergyUK
Aqdot
Active
Deep TechUK
Arkivum
Active
SoftwareUK
Arvia
Active
ClimateTechUK
Cytotrait
Active
BiotechUnited Kingdom· 2026

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Active
Amadeus Capital PartnersUK
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings